Dr. Josef CoreshAcademic
Founding Director, Optimal Aging Institute; Terry and Mel Karmazin Professor of Population Health; Professor of Medicine
Cited in UK press coverage of health & social care
5 citations
Across 1 topic, first on 10 Aug 2026, most recently 12 Aug 2026.
3 of these 5 are linkable below; the rest were counted by the coverage scan without a stored article link.
Biography
Josef Coresh, MD, PhD is the Founding Director of the Optimal Aging Institute at NYU Grossman School of Medicine and a Professor of Population Health and Medicine, holding the Terry and Mel Karmazin endowed chair. He is an epidemiologist and internationally recognised expert in aging and vascular disease epidemiology of the brain, heart, and kidney, with over 1,000 published scientific papers cited more than 420,000 times on Google Scholar. He co-led the ACHIEVE randomised controlled trial, published in The Lancet in 2023, which provided the most rigorous evidence that hearing intervention slows cognitive decline by 48% over three years in older adults at heightened dementia risk. In January 2025 he was senior author on a Nature Medicine study estimating the lifetime dementia risk after age 55 at 42%—more than twice previous estimates—and projecting approximately one million new US dementia cases annually by 2060. He has been quoted in UK and international press coverage on dementia prevention, vascular risk factors, and the preventability of age-related cognitive decline. He received the top scientific and patient impact awards of the US National Kidney Foundation (Eknoyan and Hume Awards) and the American Society of Nephrology (Belding Scribner Award).
References
- 1.Josef Coresh, MD, PhD – NYU Grossman School of Medicine faculty page — Current role, title, institute, and research interests at NYU Langone
- 2.Dr. Josef Coresh on Living a Longer, Healthier, Happier Life – NYU Langone News — Founding director role, 1,000+ papers, January 2025 Nature Medicine dementia study, advocacy positions on aging
- 3.Lifetime risk and projected burden of dementia – Nature Medicine (January 2025) — 42% lifetime dementia risk finding; projection to 1 million annual cases by 2060; Coresh as corresponding author
- 4.ACHIEVE Study Results Published, Presented – Johns Hopkins Cochlear Center — Co-PI role on ACHIEVE trial; 48% slowing of cognitive decline finding published in The Lancet, July 2023
- 5.Josef Coresh – Johns Hopkins Bloomberg School of Public Health faculty page
Expertise
Cited on
Stated areas of expertise
- Dementia risk and prevention
- Vascular disease epidemiology
- Aging and cognitive decline
- Chronic kidney disease
- Hearing loss and brain health
- Longitudinal cohort epidemiology
Notable achievements
- Co-led the ACHIEVE randomised controlled trial (published in The Lancet, July 2023), which found hearing intervention slowed cognitive decline by 48% over three years in older adults at high dementia risk. Source ↗
- Senior author of a January 2025 Nature Medicine study estimating the US lifetime dementia risk from age 55–95 at 42%, more than twice prior estimates, projecting ~1 million annual new cases by 2060. Source ↗
- Received the National Kidney Foundation's Garabed Eknoyan Award (2010) and David M. Hume Memorial Award (2015), and the American Society of Nephrology Belding Scribner Award (2020). Source ↗
- Recognised since 2014 each year as among the top 1% of researchers globally in Clinical Medicine by article citations (Thomson Reuters/Clarivate Highly Cited Researchers). Source ↗
What they’ve said
“We found if you had more risk factors, you had an elevated risk of both dementia and mortality”
director of the Optimal Aging Institute at NYU Langone Health · Dementia · 12 Aug 2026 · How 3 health factors can help delay dementia for up to 13 years ↗
“need to actively avert these factors in midlife as a strategy for preserving brain health for more than a decade”
Director of the Optimal Ageing Institute at NYU Langone · Dementia · 12 Aug 2026 · Three middle-age health rules could bring an extra 13 years without dementia, experts say ↗
“We thought focusing on time gained may help get across the benefits of averting dementia risks.”
at New York University · Dementia · 10 Aug 2026 · Three factors in midlife can delay the onset of dementia by 13 years ↗
Source references
- How 3 health factors can help delay dementia for up to 13 yearsnbcnews.com · 12 Aug 2026
- Three middle-age health rules could bring an extra 13 years without dementia, experts saynews.sky.com · 12 Aug 2026
- Three factors in midlife can delay the onset of dementia by 13 yearsnewscientist.com · 10 Aug 2026
Contact & links
- Staff pagehttps://med.nyu.edu/faculty/josef-coresh
- LinkedInhttps://www.linkedin.com/in/josef-coresh-3624a635/
Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.